Genetic inhibition of hepatic acetyl-CoA carboxylase activity increases liver fat and alters global protein acetylation
Jenny D.Y. Chow(University of Virginia), Kyle L. Hoehn(UNSW Sydney), Judit Villén(University of Washington), Robert Lawrence(University of Washington), David E. James(The University of Sydney), Frances L. Byrne(University of Virginia), Stephen H. Caldwell(University of Virginia), Nigel Turner(Garvan Institute of Medical Research), Saeko Okutsu(University of Virginia), Carolin Lackner(Ludwig Boltzmann Institute Applied Diagnostics), Brandon M. Kenwood(University of Virginia), Pere Puigserver(Harvard University), David Breen(University of Virginia), Valeria R. Mas(University of Tennessee Health Science Center), Gregory J. Cooney(Garvan Institute of Medical Research), Jose L. Tomsig(University of Virginia), Jason A. Liao(University of Virginia), Marin E. Healy(University of Virginia), John E. Dominy(Harvard University)
Cited by 107
Related Papers
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
|Nature Genetics|2003|10.6k
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
|Hepatology|2003|2.1k
Liver biopsy†
|Hepatology|2008|1.9k
Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC‐1α
|The EMBO Journal|2007|1.3k
Regulated transport of the glucose transporter GLUT4
|Nature Reviews Molecular Cell Biology|2002|1.2k